Waynesboro Hospital
Waynesboro Hospital was paid $831K by Medicaid between Sep 2020 and Nov 2024, across 81 billing codes. Its largest line is U0003, Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r — 40% of everything it billed.
FAYETTEVILLE, PA 17222
Next to other General Acute Care Hospital providers in Pennsylvania
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Paid by month
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2020 | 2,713 | $101K | |
| 2021 | 22,361 | $641K | |
| 2022 | 1,371 | $80K | |
| 2023 | 168 | $5K | |
| 2024incomplete | 518 | $5K |
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 40% | 3,853 | 3,669 | $334K |
| G0378 | Hospital observation service, per hour | 18% | 143 | 136 | $148K |
| T1015 | A visit at a community health center or clinic (one all-in rate)Clinic visit/encounter, all-inclusive | 5.5% | 1,215 | 358 | $46K |
| 80050 | General health panel | 4.3% | 755 | 740 | $35K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | 2.4% | 227 | 223 | $20K |
| 80061 | Lipid panel | 2.0% | 1,182 | 1,156 | $17K |
| 80053 | Comprehensive metabolic panel | 1.9% | 1,507 | 1,437 | $16K |
| 84443 | Thyroid stimulating hormone (TSH) | 1.9% | 698 | 685 | $16K |
| 76830 | Ultrasound, transvaginal | 1.7% | 287 | 282 | $14K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 1.7% | 347 | 337 | $14K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 1.6% | 135 | 133 | $13K |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 1.3% | 1,462 | 1,395 | $11K |
69 more codes
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 1.2% | 256 | $10K |
| 36415 | Collection of venous blood by venipuncture | <1% | 2,876 | $8K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 1,489 | $8K |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 222 | $8K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 781 | $6K |
| 87481 | <1% | 42 | $6K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 858 | $6K |
| 84702 | <1% | 294 | $5K | |
| 84466 | <1% | 275 | $5K | |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 538 | $4K |
| 86803 | <1% | 210 | $4K | |
| 82607 | <1% | 294 | $4K | |
| 97161 | <1% | 58 | $4K | |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 161 | $4K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 226 | $4K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 471 | $3K |
| 84439 | <1% | 376 | $3K | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 137 | $3K |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 104 | $3K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 107 | $3K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 108 | $3K |
| 83540 | <1% | 282 | $2K | |
| 87077 | <1% | 303 | $2K | |
| 87186 | <1% | 263 | $2K | |
| 82570 | <1% | 311 | $2K | |
| 82728 | <1% | 191 | $2K | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 327 | $2K |
| 82043 | <1% | 253 | $2K | |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 53 | $2K |
| 70553 | Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences | <1% | 13 | $2K |
| 81513 | <1% | 21 | $2K | |
| 83735 | <1% | 357 | $2K | |
| 76801 | <1% | 45 | $2K | |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | <1% | 42 | $2K |
| 85027 | <1% | 336 | $2K | |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 58 | $2K |
| 81001 | <1% | 443 | $1K | |
| 85610 | <1% | 347 | $1K | |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | <1% | 13 | $784.86 |
| 86738 | <1% | 43 | $770.75 | |
| 82248 | <1% | 117 | $707.28 | |
| 86592 | <1% | 179 | $695.49 | |
| 86140 | <1% | 215 | $661.22 | |
| 96376 | <1% | 38 | $655.60 | |
| 76536 | <1% | 13 | $624.09 | |
| 85652 | <1% | 198 | $610.07 | |
| 76641 | <1% | 12 | $547.30 | |
| 83721 | <1% | 39 | $500.36 | |
| 82746 | <1% | 40 | $463.20 | |
| 80076 | <1% | 63 | $431.88 | |
| 82565 | <1% | 96 | $427.61 | |
| 84403 | <1% | 13 | $345.60 | |
| 83690 | <1% | 73 | $273.75 | |
| 99285 | Emergency room visit (most serious) | <1% | 101 | $250.90 |
| 83001 | <1% | 12 | $233.66 | |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 14 | $231.86 |
| 86431 | <1% | 24 | $206.75 | |
| 85730 | <1% | 86 | $201.83 | |
| 87340 | <1% | 12 | $188.45 | |
| 82947 | <1% | 112 | $175.60 | |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 42 | $143.77 |
| 84484 | <1% | 95 | $118.45 | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 12 | $110.70 |
| 82950 | <1% | 12 | $77.04 | |
| 84156 | <1% | 14 | $58.46 | |
| 81003 | <1% | 13 | $43.43 | |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 0% | 12 | $0.00 |
| 71045 | Radiologic examination, chest; single view | 0% | 25 | $0.00 |
| A9585 | Injection, gadobutrol, 0.1 ml | 0% | 54 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
Who's on the registration
| Provider | Location | Paid |
|---|---|---|
| Our Lady of Bellefonte Hospital INC | Ashland, KY | $12.13M |
| The Chambersburg Hospital | Chambersburg, PA | $10.29M |
| Vna Home Health Services | York, PA | $3.99M |
| Waynesboro Hospital | Waynesboro, PA | $1.48M |
| The Chambersburg Hospital | Chambersburg, PA | $801K |
| Wellspan Surgery and Rehabilitation Hospital | York, PA | $399K |
| Our Lady of Bellefonte Hospital INC | Ashland, KY | $200K |
| Waynesboro Hospital | Wayesboro, PA | $11K |
| The Chambersburg Hospital | Chambersburg, PA | $6K |
| The Chambersburg Hospital | Chambersburg, PA | $198.19 |
| Waynesboro Hospital | Waynesboro, PA | $6.58 |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.